133 related articles for article (PubMed ID: 7180498)
1. Systemic availability of acetylsalicylic acid in human subjects after oral ingestion of three different formulations.
Petersen T; Husted SE; Pedersen AK; Geday E
Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):285-91. PubMed ID: 7180498
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol.
Brantmark B; Wåhlin-Boll E; Melander A
Eur J Clin Pharmacol; 1982; 22(4):309-14. PubMed ID: 7106166
[TBL] [Abstract][Full Text] [Related]
3. Systemic availability of acetylsalicylic acid in normal men and women and its effect on in vitro platelet aggregability.
Husted SE; Pedersen AK; Petersen T; Geday E
Eur J Clin Pharmacol; 1983; 24(5):679-82. PubMed ID: 6873151
[TBL] [Abstract][Full Text] [Related]
4. Determination of acetylsalicylic acid and salicylic acid in skin and plasma by high-performance liquid chromatography.
Pirola R; Bareggi SR; De Benedittis G
J Chromatogr B Biomed Sci Appl; 1998 Feb; 705(2):309-15. PubMed ID: 9521569
[TBL] [Abstract][Full Text] [Related]
5. Acetylsalicylic acid metabolites in blood and urine after plain and enteric-coated tablets.
Montgomery PR; Sitar DS
Biopharm Drug Dispos; 1986; 7(1):21-5. PubMed ID: 3955197
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic study of a new oral buffered acetylsalicylic acid (ASA) formulation in comparison with plain ASA in healthy volunteers.
Viganò G; Garagiola U; Gaspari F
Int J Clin Pharmacol Res; 1991; 11(3):129-35. PubMed ID: 1809699
[TBL] [Abstract][Full Text] [Related]
7. Urinary pH and plasma levels of salicylate after administration of different buffered acetylsalicylic acid formulations.
Bogentoft C; Dahl G; Magnusson A
Biopharm Drug Dispos; 1983; 4(2):137-43. PubMed ID: 6882881
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet.
Lücker PW; Wetzelsberger N; Schettler T; Rogalla K
Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):805-11. PubMed ID: 1297896
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of acetylsalicylic acid and salicylic acid after oral ingestion of plain and buffered acetylsalicylic acid in relation to bleeding time and thrombocyte function.
Proost JH; Van Imhoff GW; Wesseling H
Pharm Weekbl Sci; 1983 Feb; 5(1):22-7. PubMed ID: 6844122
[TBL] [Abstract][Full Text] [Related]
10. [Absolute bioavailability of a special sustained-release acetylsalicylic acid formulation].
Lücker PW; Swoboda M; Wetzelsberger N
Arzneimittelforschung; 1989 Mar; 39(3):391-4. PubMed ID: 2757664
[TBL] [Abstract][Full Text] [Related]
11. Plasma acetylsalicylic acid and salicylic acid levels during aspirin provocation in aspirin-sensitive subjects.
Dahlén B; Boréus LO; Anderson P; Andersson R; Zetterström O
Allergy; 1994 Jan; 49(1):43-9. PubMed ID: 8198239
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.
Roberts MS; McLeod LJ; Cossum PA; Vial JH
Eur J Clin Pharmacol; 1984; 27(1):67-74. PubMed ID: 6436031
[TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method.
Dei Cas M; Rizzo J; Scavone M; Femia E; Podda GM; Bossi E; Bignotto M; Caberlon S; Cattaneo M; Paroni R
Sci Rep; 2021 May; 11(1):10370. PubMed ID: 33990657
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses.
Buntenkötter K; Osmers M; Schenk I; Schänzer W; Machnik M; Düe M; Kietzmann M
BMC Vet Res; 2017 Jan; 13(1):28. PubMed ID: 28103874
[TBL] [Abstract][Full Text] [Related]
15. Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin/diethyl ether mixture and oral aspirin in acute herpes zoster and postherpetic neuralgia.
Bareggi SR; Pirola R; De Benedittis G
Eur J Clin Pharmacol; 1998 May; 54(3):231-5. PubMed ID: 9681665
[TBL] [Abstract][Full Text] [Related]
16. A simultaneous determination of acetylsalicylic acid, salicylic acid and salicylamide in plasma by gas liquid chromatography.
Rance MJ; Jordan BJ; Nichols JD
J Pharm Pharmacol; 1975 Jun; 27(6):425-9. PubMed ID: 237091
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
Patrick J; Dillaha L; Armas D; Sessa WC
Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of salicylic acid following administration of aspirin tablets and three different forms of soluble aspirin in normal subjects.
Gatti G; Barzaghi N; Attardo Parrinello G; Vitiello B; Perucca E
Int J Clin Pharmacol Res; 1989; 9(6):385-9. PubMed ID: 2517497
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous extraction of acetylsalicylic acid and salicylic acid from human plasma and simultaneous estimation by liquid chromatography and atmospheric pressure chemical ionization/tandem mass spectrometry detection. Application to a pharmacokinetic study.
Nirogi R; Kandikere V; Mudigonda K; Ajjala D; Suraneni R; Thoddi P
Arzneimittelforschung; 2011; 61(5):301-11. PubMed ID: 21755814
[TBL] [Abstract][Full Text] [Related]
20. Plasma salicylate levels and platelet function after acute and chronic administration of slow-release acetylsalicylic acid (Monobeltin).
Rehders K; Simrock R; Spahn H; Mutschler E; Breddin HK
Eur J Clin Pharmacol; 1985; 27(6):683-7. PubMed ID: 3987774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
